Matthew W Sherwood1, J Matthew Brennan2, Kalon K Ho3, Frederick A Masoudi4, John C Messenger4, W Douglas Weaver5, David Dai2, Eric D Peterson3. 1. Division of Cardiovascular Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina. Electronic address: matthew.sherwood@dm.duke.edu. 2. Division of Cardiovascular Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina. 3. Department of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 4. Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 5. Division of Cardiology, Henry Ford Medical Center, Detroit, Michigan.
Abstract
OBJECTIVES: The goal of this study was to examine the calibration of a validated risk-adjustment model in very high-risk percutaneous coronary intervention (PCI) cases and assess whether sites' case mix affects their performance ratings. BACKGROUND: There are concerns that treating PCI patients with particularly high-risk features such as cardiogenic shock or prior cardiac arrest may adversely impact hospital performance ratings. However, there is little investigation on the validity of these concerns. METHODS: We examined 624,286 PCI procedures from 1,168 sites that participated in the CathPCI Registry in 2010. Procedural risk was estimated using the recently published Version 4 National Cardiovascular Data Registry (NCDR) PCI risk-adjusted mortality (RAM) model. We calculated observed/expected mortality using several risk classification methods, and simulated hospital performance after combining their highest risk cases over 2 years into a single year. RESULTS: In 2010, crude in-hospital PCI mortality was 1.4%. The NCDR model was generally well calibrated among high risk, however there was slight overprediction of risk in extreme cases. Hospitals treating the highest overall expected risk PCI patients or those treating the top 20% of high-risk cases had lower (better) RAM ratings than centers treating lower-risk cases (1.25% vs. 1.51%). The observed/expected ratio for top-risk quintile versus low-risk quintile was 0.91 (0.87 to 0.96) versus 1.10 (1.03 to 1.17). Combining all the high-risk patients over a 2-year period into a single year also did not negatively impact the site's RAM ratings. CONCLUSIONS: Evaluation of a contemporary sample of PCI cases across the United States showed no evidence that treating high-risk PCI cases adversely affects hospital RAM rates.
OBJECTIVES: The goal of this study was to examine the calibration of a validated risk-adjustment model in very high-risk percutaneous coronary intervention (PCI) cases and assess whether sites' case mix affects their performance ratings. BACKGROUND: There are concerns that treating PCI patients with particularly high-risk features such as cardiogenic shock or prior cardiac arrest may adversely impact hospital performance ratings. However, there is little investigation on the validity of these concerns. METHODS: We examined 624,286 PCI procedures from 1,168 sites that participated in the CathPCI Registry in 2010. Procedural risk was estimated using the recently published Version 4 National Cardiovascular Data Registry (NCDR) PCI risk-adjusted mortality (RAM) model. We calculated observed/expected mortality using several risk classification methods, and simulated hospital performance after combining their highest risk cases over 2 years into a single year. RESULTS: In 2010, crude in-hospital PCI mortality was 1.4%. The NCDR model was generally well calibrated among high risk, however there was slight overprediction of risk in extreme cases. Hospitals treating the highest overall expected risk PCI patients or those treating the top 20% of high-risk cases had lower (better) RAM ratings than centers treating lower-risk cases (1.25% vs. 1.51%). The observed/expected ratio for top-risk quintile versus low-risk quintile was 0.91 (0.87 to 0.96) versus 1.10 (1.03 to 1.17). Combining all the high-risk patients over a 2-year period into a single year also did not negatively impact the site's RAM ratings. CONCLUSIONS: Evaluation of a contemporary sample of PCI cases across the United States showed no evidence that treating high-risk PCI cases adversely affects hospital RAM rates.
Authors: Gregory J Dehmer; Michael A Kutcher; Syamal K Dey; Richard E Shaw; William S Weintraub; Kristi Mitchell; Ralph G Brindis Journal: Am J Cardiol Date: 2006-11-29 Impact factor: 2.778
Authors: P D McGrath; D E Wennberg; J D Dickens; A E Siewers; F L Lucas; D J Malenka; M A Kellett; T J Ryan Journal: JAMA Date: 2000-12-27 Impact factor: 56.272
Authors: Mauro Moscucci; Kim A Eagle; David Share; Dean Smith; Anthony C De Franco; Michael O'Donnell; Eva Kline-Rogers; Sandeep M Jani; David L Brown Journal: J Am Coll Cardiol Date: 2005-06-07 Impact factor: 24.094
Authors: Frederic S Resnic; Sharon-Lise T Normand; Thomas C Piemonte; Samuel J Shubrooks; Katya Zelevinsky; Ann Lovett; Kalon K L Ho Journal: J Am Coll Cardiol Date: 2011-02-22 Impact factor: 24.094
Authors: J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel Journal: N Engl J Med Date: 1999-08-26 Impact factor: 91.245
Authors: William Z Chancellor; J Hunter Mehaffey; Jared P Beller; Elizabeth D Krebs; Robert B Hawkins; Kenan Yount; Clifford E Fonner; Alan M Speir; Mohammed A Quader; Jeffrey B Rich; Leora T Yarboro; Nicholas R Teman; Gorav Ailawadi Journal: J Thorac Cardiovasc Surg Date: 2019-01-26 Impact factor: 5.209
Authors: Lloyd W Klein; Kishore J Harjai; Fred Resnic; William S Weintraub; H Vernon Anderson; Robert W Yeh; Dmitriy N Feldman; Osvaldo S Gigliotti; Kenneth Rosenfeld; Peter Duffy Journal: Catheter Cardiovasc Interv Date: 2016-11-10 Impact factor: 2.692
Authors: Gregory J Dehmer; Jonathan Jennings; Ruth A Madden; David J Malenka; Frederick A Masoudi; Charles R McKay; Debra L Ness; Sunil V Rao; Frederic S Resnic; Michael E Ring; John S Rumsfeld; Marc E Shelton; Michael C Simanowith; Lara E Slattery; William S Weintraub; Ann Lovett; Sharon-Lise Normand Journal: J Am Coll Cardiol Date: 2015-11-18 Impact factor: 24.094
Authors: Akash Kataruka; Charles C Maynard; Ravi S Hira; Larry Dean; Todd Dardas; Hitinder Gurm; Josiah Brown; Michael E Ring; Jacob A Doll Journal: J Am Heart Assoc Date: 2022-09-03 Impact factor: 6.106